Targeting of retroviral vectors through protease-substrate interactions

Gene Therapy

Volumn 3, Issue 4, 1996, Pages 280-286

  Nilson, B H K ^a   Morling, F J ^a   Cosset, F L ^b   Russell, S J ^a  

^a MEDICAL RESEARCH COUNCIL   (United Kingdom)

^b CNRS   (France)

Author keywords

Gene therapy; Retroviral vectors; Targeted gene delivery; Two step targeting

Indexed keywords

EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; PROTEINASE; VIRUS GLYCOPROTEIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; EXPRESSION VECTOR; GENE TARGETING; GENE THERAPY; HUMAN; HUMAN CELL; LIGAND BINDING; NONHUMAN; PHAGE DISPLAY; PRIORITY JOURNAL; PROTEIN DEGRADATION; RETROVIRUS; TARGET CELL;

3T3 CELLS; AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; BINDING SITES; CELL LINE; DNA, RECOMBINANT; ENDOPEPTIDASES; EPIDERMAL GROWTH FACTOR; FACTOR XA; GENE PRODUCTS, ENV; GENE TARGETING; GENE THERAPY; GENETIC VECTORS; HUMANS; LIGANDS; MICE; MOLECULAR SEQUENCE DATA; RECOMBINANT FUSION PROTEINS; RETROVIRIDAE; SUBSTRATE SPECIFICITY;

ANIMALIA; UNIDENTIFIED RETROVIRUS;

EID: 0029917238     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Vile RG, Russell SJ. Retroviruses as vectors. Br Med Bull 1995; 51: 12-30.
2. Miller AD. Retroviral vectors. Curr Top Microbiol Immunol 1992; 158: 1-24.
3. August JT et al. A proposed nomenclature for the virion proteins of oncogenic RNA viruses. Virology 1974; 60: 595-601.
4. Ikeda H, Hardy W, Tress E, Fleissner E. Chromatographic separation and antigenic analysis of proteins of the oncornaviruses. V. Identification of a new murine viral protein, p15(E). J Virol 1975; 16: 53-61.
5. Kamps CA, Lin YC, Wong PKY. Oligomerization and transport of the envelope protein of Moloney murine leukemia virus-TB and of ts1, a neurovirulent temperature-sensitive mutant of MoMuLV-TB. Virology 1991; 184: 687-694.
6. Battini JL, Danos O, Heard JM. Receptor-binding domain of murine leukemia virus envelope glycoproteins. J Virol 1995; 69: 713-719.
7. Albritton LM, Tseng L, Scadden D, Cunningham JM. A putative murine ecotropic retrovirus receptor gene encodes a multiple membrane-spanning protein and confers susceptibility to virus infection. Cell 1995; 57: 659-666.
8. Albritton LM, Jung Woo K, Tseng L, Cunningham JM. Envelope-binding domain in the cationic amino acid transporter determines the host range of ecotropic murine retroviruses J Virol 1993; 67: 2091-2096.
9. van Zeijl M et al. A human amphotropic retrovirus receptor in a second member of the gibbon ape leukemia virus receptor family. Proc Natl Acad Sci USA 1994; 91: 1168-1172.
10. Miller DG, Edwards RH, Miller AD. Cloning of the cellular receptor for amphotropic murine retroviruses reveals homology to that for gibbon ape leukemia virus. Proc Natl Acad Sci USA 1994; 91: 78-82.
11. Kavanaugh MP et al. Cell-surface receptors for gibbon ape leukemia virus and amphotropic murine retrovirus are inducible sodium-dependent phosphate symporters. Proc Natl Acad Sci USA 1994; 91: 7071-7075.
12. Chu THT, Dornburg R. Retroviral vector particles displaying the antigen-binding site of an antibody enable cell-type-specific gene transfer. J Virol 1995; 69: 2659-2663.
13. Cosset FL et al. Retroviral retargeting by envelopes expressing an N-terminal binding domain. J Virol 1995; 69: 6314-6322.
14. Han X, Kasahara N, Yuet Wai K. Ligand-directed retroviral targeting of human breast cancer cells. Proc Natl Acad Sci USA 1995; 92: 9747-9751.
15. Valsesia-Wittmann S et al. Modifications in the binding domain of avian retrovirus envelope protein to redirect the host range of retroviral vectors. J Virol 1994; 68: 4609-4619.
16. Kasahara N, Dozy AM, Kan YW. Tissue-specific targeting of retroviral vectors through ligand-receptor interactions. Science 1994; 266: 1373-1376.
17. Somia NV, Zoppe M, Verma IM. Generation of targeted retroviral vectors by using single-chain variable fragment: an approach to in vivo gene delivery. Proc Natl Acad Sci USA 1995; 92: 7570-7574.
18. Russell SJ, Hawkins RE, Winter G. Retroviral vectors displaying functional antibody fragments. Nucleic Acids Res 1993; 21: 1081-1085.
19. Lottenberg R, Christensen U, Jackson CM, Coleman PL. Assay of coagulation proteases using peptide chromogenic and fluorogenic substrates. Methods Enzymol 1981; 80: 341-361.
20. Cosset FL et al. High-titer packaging cells producing recombinant retroviruses resistant to human serum. J Virol 1995; 69: 7430-7436.
21. Pryzdial ELG, Wright JF. Prothrombinase assembly on an enveloped virus: evidence that the cytomegalovirus surface contains procoagulant phospholipid. Blood 1994; 84: 3749-3757.
22. Poustis Delpont C et al. Characterization and purification of a guanidinobenzoatase: a possible marker of human renal carcinoma. Cancer Res 1992; 52: 3622-3628.
23. Sato H et al. A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature 1994; 370: 61-65.
24. Chen WT et al. Membrane proteases as potential diagnostic and therapeutic targets for breast malignancy. Breast Cancer Res Treat 1994; 31: 217-226.
25. Shipp MA, Look AT Hematopoietic differentiation antigens that are membrane-associated enzymes: cutting is the key! Blood 1993; 82: 1052-1070.
26. Murakami T, Hatton T, Takatsuki K. A principal neutralizing domain of human immunodeficiency virus type 1 interacts with proteinase-like molecule(s) at the surface of Molt-4 clone 8 cells. Biochim Biophys Acta Protein Struct Molec Enzymol 1991; 1079: 279-284.
27. McCafferry J, Griffiths AD, Winter G, Chiswell DJ. Phage antibodies: filamentous phage displaying antibody variable domains. Nature 1990; 348: 552-554.
28. Matthews DJ, Wells JA. Substrate phage: selection of protease substrates by monovalent phage display. Science 1993; 260: 1113-1117.
29. Smith MM, Shi L, Navre M. Rapid identification of highly active and selective substrates for stromelysin and matrilysin using bacteriophage peptide display libraries. J Biol Chem 1995; 270: 6440-6449.
30. Bubeník J et al. Established cell line of urinary bladder carcinoma (T24) containing tumor-specific antigen. Int J Cancer 1973; 11: 765-773.
31. Sambrook J, Fritsch EF, Maniatis T (eds). Molecular Cloning: A Laboratory Manual, 2 edn. Cold Spring Harbor Press: NY, 1989.
32. Takeuchi Y et al. Type C retrovirus inactivation by human complement is determined by both the viral genome and the producer cell. J Virol 1994; 68: 8001-8007.